ask="N/A"
ask_size="N/A"
average_daily_volume="334973"
bid="1.5800"
bid_size="1000"
book_value="0.3390"
change="+0.0299"
change_from_200_day_moving_average="0.0096"
change_from_50_day_moving_average="0.0631"
change_from_52_week_high="-3.4201"
change_From_52_week_low="0.5699"
change_in_percent="+1.8121%"
close="1.6799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4870"
ebitda="-12.32M"
eps_estimate_current_year="-1.5800"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-0.8800"
ex_dividend_date="N/A"
float_shares="3683000"
high="1.7000"
high_52_weeks="5.1000"
last_trade_date="2/15/2017"
last_trade_price="1.6799"
last_trade_size="100"
last_trade_time="3:59pm"
low="1.6300"
low_52_weeks="1.1100"
market_capitalization="16.10M"
moving_average_200_day="1.6703"
moving_average_50_day="1.6169"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.6400"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+0.5760%"
percent_change_from_50_day_moving_average="+3.8996%"
percent_change_from_52_week_high="-67.0608%"
percent_change_from_52_week_low="+51.3423%"
previous_close="1.6500"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.8673"
price_per_sales="31.0780"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.7600"
stock_exchange="NCM"
symbol="EYEG"
volume="50618"
weeks_range_52="1.1100 - 5.1000"
